In order to explore the clinical implications of CRM1 expression in ovarian cancer progression and contextualise our results, we used PrognoScan [48], an online tool capable of correlating patients prognosis with gene expression by systematically mining public databases. Here, XPO1 is linked to ovarian cancer.